TCM Biotech International Corp. (4169.TWO)

TWD 58.3

(0.52%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 969.61 Million 802.42 Million 702.04 Million 737.07 Million 568.63 Million
Cost of Revenue 489.45 Million 353.93 Million 343.32 Million 368.15 Million 295.33 Million
Gross Profit 480.16 Million 448.48 Million 358.71 Million 368.92 Million 273.3 Million
Operating Expenses 457.83 Million 422.7 Million 356.58 Million 331.12 Million 258.27 Million
Selling, General and Administrative Expenses 380.37 Million 340.9 Million 276.13 Million 259.59 Million 214.96 Million
Research and Development Expenses 77.46 Million 81.8 Million 80.44 Million 71.53 Million 44.63 Million
Other Expenses - 70 Thousand 2.05 Million 961 Thousand -
Cost and Expenses 947.29 Million 776.63 Million 699.91 Million 699.27 Million 553.6 Million
Operating Income 22.32 Million 25.99 Million 4.22 Million 38.83 Million 13.7 Million
Interest Expense 2.77 Million 2.38 Million 1.97 Million 1.94 Million 2.19 Million
Income Tax Expense 3.45 Million 4.86 Million 384 Thousand 10.59 Million 6.41 Million
Earnings before Tax 22.03 Million 23.12 Million 2.25 Million 36.13 Million 12.92 Million
Net Income 18.57 Million 18.26 Million 1.87 Million 25.54 Million 6.51 Million
Earnings Per Share Basic 0.35 0.37 0.04 0.50 0.13
Earnings Per Share Diluted 0.35 0.37 0.04 0.50 0.13
Weighted Average Shares Outstanding 53.02 Million 49.04 Million 50.73 Million 50.48 Million 50.5 Million
Weighted Average Shares Outstanding (Diluted) 53.04 Million 49.1 Million 50.73 Million 50.52 Million 50.54 Million
Gross Margin 0.50 0.56 0.51 0.50 0.48
EBIT Margin 0.05 0.06 0.03 0.07 0.05
Profit Margin 0.02 0.02 0.00 0.03 0.01
EBITDA 46.69 Million 45.99 Million 22.28 Million 53.9 Million 28.13 Million
Earnings Before Tax Margin 0.02 0.03 0.01 0.05 0.02

Income Statement Charts